Nilesh Mahajan

Nilesh Mahajan

Auto-generated profile, based on publicly available information

Nilesh Mahajan

Dadasaheb Balpande College of Pharmacy, Rashtrasant Tukadoji Maharaj Nagpur University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
RKRohini Kharwade
Rohini Kharwade
SMSachin More
Sachin More
AWAmol Warokar
Amol Warokar
PAPratibha Agrawal
Pratibha Agrawal
NMNilesh Mahajan
Nilesh Mahajan

1 May 2022 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
RKRohini Kharwade
Rohini Kharwade
PBPayal Badole
Payal Badole
NMNilesh Mahajan
Nilesh Mahajan
RKRohini Kharwade
Rohini Kharwade
Compared to other nano polymers, dendrimers have novel three-dimensional, synthetic hyperbranched, nano-polymeric structures. These supramolecular dendritic structures have a high degree of significant surface and core functionality in the transportation of drugs for targeted therapy, specifically in host-guest response, gene transfer therapy, and imaging of biological systems. However, there are conflicting shreds of evidence regarding biological safety and dendrimers toxicity due to their positive charge at the surface. It includes cytotoxicity, hemolytic toxicity, haematological toxicity, immunogenicity, and in vivo toxicity. Surface modification of the dendrimer group is one of the methods to resolve these issues. This review aimed at investigating different strategies that can reduce toxicity and improve the biocompatibility of different dendrimers. From that viewpoint, we broaden the structural and safe characteristics of the dendrimers in the biomedical and pharmaceutical fields.

22 February 2024 in ACS Omega
Verified
Journal Article
Open access
SDSudharshan Reddy Dachani
Sudharshan Reddy Dachani
MKMohammed Kaleem
Mohammed Kaleem
MMMd. Ali Mujtaba
Md. Ali Mujtaba
NMNilesh Mahajan
Nilesh Mahajan
SASayyed A. Ali
Sayyed A. Ali
SKSanjay Kumar
Sanjay Kumar
Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is crucial for successful treatment, as the disease becomes more challenging to cure as it progresses. However, identifying new drugs, achieving clinical success, and overcoming drug resistance remain significant challenges. To overcome these obstacles and provide effective treatment, it is crucial to understand the causes of skin cancer, how cells grow and divide, factors that affect cell growth, and how drug resistance occurs. In this review, we have explained various therapeutic approaches for SC treatment via ligands, targeted photosensitizers, natural and synthetic drugs for the treatment of SC, an epigenetic approach for management of melanoma, photodynamic therapy, and targeted therapy for BRAF-mutated melanoma. This article also provides a detailed summary of the various natural drugs that are effective in managing melanoma and reducing the occurrence of skin cancer at early stages and focuses on the current status and future prospects of various therapies available for the management of skin cancer.

6 May 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
FAFrazer Andrade
Frazer Andrade
CJChristopher Jenipher
Christopher Jenipher
NGNilambari Gurav
Nilambari Gurav
SNSameer Nadaf
Sameer Nadaf
MKMohd Shahnawaz Khan
Mohd Shahnawaz Khan
Shailendra Shivaji GuravShailendra Shivaji Gurav
Shailendra Shivaji Gurav
1

3 June 2024 in Phytotherapy Research
Verified
Journal Article
Closed access
VSVaishnavi Shete
Vaishnavi Shete
NMNilesh M. Mahajan
Nilesh M. Mahajan
RSRuchi Shivhare
Ruchi Shivhare
AAAshish Akkewar
Ashish Akkewar
AGAmisha Gupta
Amisha Gupta
Shailendra Shivaji GuravShailendra Shivaji Gurav
Shailendra Shivaji Gurav

1 January 2023 in Drug Delivery
Verified
Journal Article
Open access
VSVaishnavi S. Shete
Vaishnavi S. Shete
Darshan Ramkrishnarao TelangeDarshan Ramkrishnarao Telange
Darshan Ramkrishnarao Telange
NMNilesh M. Mahajan
Nilesh M. Mahajan
APAnil M Pethe
Anil M Pethe
DMDEBARSHI KAR MAHAPATRA
DEBARSHI KAR MAHAPATRA
Genistein (GEN), an isoflavonoid, offers multifunctional biological activities. However, its poor oral bioavailability, aqueous solubility, extensive metabolism, and short half-life restricted its clinical use. Therefore, the Phospholipon®90H complex of genistein (GPLC) was prepared to enhance its biopharmaceutical properties and anti-inflammatory activity. GPLC was characterized by employing particle size and zeta potential, Fourier transforms infrared spectrophotometry, differential scanning calorimetry, powder x-ray diffractometry, proton nuclear magnetic resonance, aqueous solubility, in vitro dissolution, ex vivo permeation, oral bioavailability and in vivo anti-inflammatory activity. The complex showed high entrapment of GEN (∼97.88% w/w) within the Phospholipon®90H matrix. Particle size and zeta potential studies confirmed the small particle size with the modest stability of GPLC. The characterization analysis supported the formation of GPLC through the participation of hydrogen bonding between GEN and Phospholipon®90H. GPLC significantly enhanced the aqueous solubility (∼2-fold) compared to GEN. Dissolution studies revealed that GPLC drastically improved the GEN dissolution rate compared to GEN. Likewise, the complex improved the permeation rate across the membrane compared to GEN. GPLC formulation significantly enhanced the oral bioavailability of GEN via improving its Cmax, tmax, AUC, half-life and mean residence time within the blood circulation compared to GEN. The GPLC (∼20 mg/kg, p.o.) remarkably inhibited the increase in paw edema up to 5 h, compared to GEN and diclofenac. Results suggest that the Phospholipon®90 complex is a superior and promising carrier for enhancing the biopharmaceutical parameters of GEN and other bioactive with similar properties. Graphical Abstract